PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TECH | Kelderman Kim | Chief Executive Officer | Jul 28 '26 | Option Exercise | 47.60 | 35,000 | 1,666,000 | 100,799 | Jul 30 |
| TECH | Kelderman Kim | Chief Executive Officer | May 05 '26 | Option Exercise | 47.60 | 26,692 | 1,270,539 | 89,750 | May 07 |
| TECH | Kelderman Kim | Chief Executive Officer | Apr 22 '26 | Option Exercise | 0.00 | 11,344 | 0 | 64,421 | Apr 24 |
| TECH | Kelderman Kim | Chief Executive Officer | Apr 14 '26 | Option Exercise | 0.00 | 36,500 | 0 | 85,165 | Apr 16 |
| TECH | Kelderman Kim | Chief Executive Officer | Aug 15 '25 | Option Exercise | 0.00 | 8,543 | 0 | 55,273 | Aug 19 |
| TECH | Kelderman Kim | Chief Executive Officer | Jul 22 '25 | Option Exercise | 44.33 | 48,176 | 2,135,642 | 90,379 | Jul 24 |
| TECH | Kelderman Kim | Chief Executive Officer | Jul 15 '25 | Option Exercise | 44.33 | 36,132 | 1,601,732 | 75,136 | Jul 17 |
| TECH | Kelderman Kim | Chief Executive Officer | Jan 27 '25 | Option Exercise | 37.70 | 13,392 | 504,878 | 52,396 | Jan 29 |
| TECH | Kelderman Kim | Chief Executive Officer | Jan 27 '25 | Sale | 77.29 | 13,392 | 1,035,013 | 39,004 | Jan 29 |
| TECH | Kelderman Kim | Chief Executive Officer | Aug 29 '24 | Option Exercise | 66.97 | 1,492 | 99,919 | 41,434 | Sep 03 |
| TECH | Kelderman Kim | Chief Executive Officer | Jul 31 '24 | Option Exercise | 37.70 | 14,000 | 527,800 | 49,421 | Aug 02 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 24 '23 | Option Exercise | 47.60 | 2,100 | 99,960 | 21,225 | Aug 28 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 05 '23 | Option Exercise | 0.00 | 8,060 | 0 | 23,264 | Aug 08 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 23 '22 | Option Exercise | 0.00 | 663 | 0 | 6,848 | Aug 25 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 07 '22 | Option Exercise | 0.00 | 2,363 | 0 | 0 | Aug 09 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Feb 08 '22 | Option Exercise | 150.78 | 1,989 | 299,901 | 1,989 | Feb 10 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Nov 19 '21 | Option Exercise | 150.78 | 500 | 75,390 | 500 | Nov 23 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Nov 19 '21 | Sale | 505.38 | 500 | 252,689 | 0 | Nov 23 |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Sep 22 '21 | Sale | 529.04 | 822 | 434,871 | 0 | Sep 24 |